Partilhar
Informação da revista
Os mais lidos
21868
Two years later, azithromycin for COVID-19 and the effect on the heart, is it still relevant?Sérgio Matoso Laranjo
Rev Port Cardiol. 2022;41:557-8
21868
Open access
15420
Documento de Consenso sobre Estratificação de Risco Cardiovascular e estudo da doença coronária em Portugal: a posição dos Grupos de Estudo de Cardiologia Nuclear, Ressonância Magnética e Tomografia Computorizada Cardíaca, de Ecocardiografia e de Fisiopatologia do Esforço e Reabilitação CardíacaNuno Bettencourt, Lígia Mendes, José Paulo Fontes, Pedro Matos, Catarina Ferreira, Ana Botelho, Sofia Carvalho, Anaí Durazzo, ... em nome do GECNRMTC, do GEE e do GEFERC da SPC
Rev Port Cardiol. 2022;41:241-51
15420
Open access
6046
The impact of the COVID-19 pandemic on acute coronary syndrome admissions to a tertiary care hospital in PortugalJoão Calvão, Ana Filipa Amador, Catarina Martins da Costa, Paulo Maia Araújo, Teresa Pinho, João Freitas, Sandra Amorim, Filipe Macedo
Rev Port Cardiol. 2022;41:147-52
6046
Open access
5779
Evaluation of myocardial performance index in patients with COVID-19: An echocardiographic follow-up studyHakan Kaya, Ramazan Asoglu, Abdulmecit Afsin, Hakan Tibilli, Ercan Kurt, Safiye Kafadar, Umut Gulacti, Huseyin Kafadar
Rev Port Cardiol. 2022;41:455-61
5779
Open access
5576
Myocardial T1 mapping with magnetic resonance imaging – a useful tool to understand the diseased heartAndreia S. Gaspar, Sérgio Maltês, Hugo Marques, Rita G. Nunes, António Ferreira
Rev Port Cardiol. 2022;41:61-9
5576
Open access
5242
Is amiodarone still a reasonable therapeutic option for rhythm control in atrial fibrillation?Sérgio Barra, João Primo, Helena Gonçalves, Serge Boveda, Rui Providência, Andrew Grace
Rev Port Cardiol. 2022;41:783-9
5242
Open access
5234
Worrisome trends of ST-elevation myocardial infarction during the Covid-19 pandemic: Data from Portuguese centersLuís Oliveira, Rui Campante Teles, Carina Machado, Sérgio Madeira, Nélson Vale, Carla Almeida, João Brito, Sílvio Leal, ... Miguel Mendes
Rev Port Cardiol. 2022;41:465-71
5234
Open access
4656
ST-elevation myocardial infarction in the Covid-19 pandemic: A step backward in a success storyHenrique Cyrne Carvalho
Rev Port Cardiol. 2022;41:473-4
4656
Open access
4580
Myocardial performance index: Is it time to revisit this old parameter in COVID-19 patients?Ana Teresa Timóteo
Rev Port Cardiol. 2022;41:463-4
4580
Open access
4476
Digital home-based multidisciplinary cardiac rehabilitation: How to counteract physical inactivity during the COVID-19 pandemicRita Pinto, Madalena Lemos Pires, Mariana Borges, Mariana Liñan Pinto, Catarina Sousa Guerreiro, Sandra Miguel, Olga Santos, Inês Ricardo, ... Ana Abreu
Rev Port Cardiol. 2022;41:209-18
4476
Open access
4299
Mavacamten, a novel revolutionizing therapy in hypertrophic obstructive cardiomyopathy: A literature reviewTiago Aguiar, Elisabete Martins
Rev Port Cardiol. 2022;41:693-703
4299
Open access
4186
Remote invasive monitoring of pulmonary artery pressures in heart failure patients: Initial experience in Portugal in the context of the Covid-19 pandemicVera Vaz Ferreira, Tiago Pereira-da-Silva, Duarte Cacela, Rui Cruz Ferreira
Rev Port Cardiol. 2022;41:381-90
4186
Open access
4024
Protocol-based cardiotoxicity monitoring in hydroxychloroquine medicated COVID-19 pediatric patientsInês Hormigo, Tiago Milheiro Silva, Sérgio Laranjo, Conceição Trigo, Ana Margarida Garcia, Catarina Gouveia, Maria João Brito
Rev Port Cardiol. 2022;41:155-63
4024
Open access
3885
Stent-Save a Life international survey on the practice of primary percutaneous coronary intervention during the COVID-19 pandemicHélder Pereira, Christoph Naber, Sandrine Wallace, Tóth Gabor, Sayfollah Abdi, Bagrat Alekyan, Thomas Alexander, Carolina Artucio, ... Jan Piek
Rev Port Cardiol. 2022;41:221-7
3885
Open access
3846
Oral administration of oleuropein and olive leaf extract has cardioprotective effects in rodents: A systematic reviewRafaella Câmara Rocha Menezes, Kathleen Kruger Peres, Marina Tuerlinckx Costa-Valle, Larissa Slongo Faccioli, Eliane Dallegrave, Juliano Garavaglia, Simone Morelo Dal Bosco
Rev Port Cardiol. 2022;41:167-75
3846
Open access
3798
The updated pre-test probability model of the 2019 ESC guidelines improves prediction of obstructive coronary artery diseasePedro M. Lopes, Francisco Albuquerque, Pedro Freitas, Bruno M.L. Rocha, Gonçalo J.L. Cunha, Ana Coutinho Santos, João Abecasis, Sara Guerreiro, ... António M. Ferreira
Rev Port Cardiol. 2022;41:445-52
3798
Open access
3713
Catheter ablation of atrial fibrillation: What we can say after more than 20 years of worldwide experienceMiguel Ventura
Rev Port Cardiol. 2022;41:649-51
3713
Open access
3421
Congenital atrioventricular heart block: From diagnosis to treatmentClara Melim, Joana Pimenta, José Carlos Areias
Rev Port Cardiol. 2022;41:231-40
3421
Open access
3395
NT-proBNP for heart failure diagnosis in Primary Care: Costs or savings? A budget impact studyCândida Fonseca, Paulo Bettencourt, Dulce Brito, Helena Febra, Álvaro Pereira, Victória Genovez, Nelson Lopes
Rev Port Cardiol. 2022;41:183-93
3395
Open access
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.